In comparison, semaglutide, the active compound in Ozempic and Wegovy, achieved a 13.9% weight reduction over 68 weeks, while tirzepatide (found in Zepbound and Mounjaro), another leading contender, produced 17.8% weight loss over 72 weeks
Request that your appeal be reviewed by a board-certified endocrinologist or obesity medicine specialist
Researchers working with multiple peptides simultaneously should be particularly careful about labeling
Its also found another medication, Birks Ang says
What sets it apart is how it works, targeting three hormone pathways involved in appetite, digestion, and metabolism rather than focusing on hunger alone
But many medical professionals advise that BMI alone is not enough to measure a persons health risks because it doesnt account for factors like body composition and genetics